Advertisement

UCLA awarded $2.7 million to study AI role in improving cancer diagnosis

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Researchers from the David Geffen School of Medicine at UCLA and UCLA Jonsson Comprehensive Cancer Center have received a $2.7 million grant from NCI to develop techniques to improve the quality of prostate magnetic resonance imaging and new artificial intelligence methods that use prostate MRI to assist cancer diagnosis.

The five-year project, led by Kyung Sung, associate professor of radiology, and Holden Wu, associate professor of radiology, bioengineering and biomedical physics, will help radiologists improve their ability to diagnose prostate cancer and help identify and predict the aggressiveness of the disease.

The new techniques will be evaluated in men who undergo prostate MRI and proceed to biopsy or surgery.

Previous studies led by Sung have shown artificial intelligence can perform as well as experienced radiologists in detecting prostate cancer. Improvements to the current system could help not only save time but potentially provide diagnostic guidance to less-experienced radiologists. Sung and Wu have also developed advanced quantitative MRI techniques that will be combined with artificial intelligence to maximize the performance for prostate cancer diagnosis.

Advertisement
Advertisement
Advertisement
Advertisement

YOU MAY BE INTERESTED IN

In an effort to target the right patients, genetic screening is becoming more common in clinical trials. But incorporating it can be complex and add a significant burden for both patients and clinical trial sites. Genetic counseling can streamline that process and help drug and gene therapy developers expedite the recruitment of genetically-eligible participants for their trials and use genetic testing results to accelerate the speed and success of clinical trials.
Advertisement
Advertisement